Srinivas Chollangi

Srinivas Chollangi has extensive experience in the pharmaceutical and biotechnology industries, currently serving as Executive Director of CMC Tech Ops at Stylus Medicine since January 2023. Previously, Srinivas held the position of Senior Director at Sanofi, leading cross-functional teams in the development and manufacturing of gene therapy drug candidates for indications such as Muscular Dystrophy and Haemophilia A. Srinivas's career includes significant roles at Voyager Therapeutics, Inc., where the successful IND application for an AAV-based therapy targeting Huntington's Disease was achieved, and at Bristol-Myers Squibb, where innovative continuous manufacturing processes were implemented. Academic achievements include a Ph.D. in Bioengineering from the University of Oklahoma and an MBA in Finance from The Wharton School.